Biontech provides business and pipeline updates at 43rd annual j.p. morgan healthcare conference

Mainz, germany, january 14, 2025 (globe newswire) -- biontech se (nasdaq: bntx, “biontech” or “the company”) today will present its 2025 strategic priorities and progress on the company's pipeline of mrna therapeutics, immunomodulators, and targeted therapies at the 43rd annual j.p. morgan healthcare conference in san francisco, california.
BNTX Ratings Summary
BNTX Quant Ranking